A comparative analysis of multiple sclerosis-relevant anti-inflammatory properties of ethyl pyruvate and dimethyl fumarate

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2493-2503

  Miljković, Djordje ^a   Blazevski, Jana ^a   Petković, Filip ^a   Djedović, Neda ^a   Momcilović, Miljana ^a   Stanisavljević, Suzana ^a   Jevtić, Bojan ^a   Stojković, Marija Mostarica ^b   Spasojević, Ivan ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ETHYL PYRUVATE; FUMARIC ACID DIMETHYL ESTER; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; THIOL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYTOKINE; FUMARIC ACID DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PYRUVIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENCEPHALITOGENIC T CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VIVO STUDY; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY T LYMPHOCYTE; RELAPSE; SCORING SYSTEM; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; IMMUNOBLOTTING; LYMPH NODE; METABOLISM; MONONUCLEAR CELL; SECRETION (PROCESS); SPINAL CORD;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; FUMARATES; HUMANS; IMMUNOBLOTTING; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPH NODES; MACROPHAGES; MICROGLIA; MULTIPLE SCLEROSIS; NF-KAPPA B; PYRUVATES; RATS; REACTIVE OXYGEN SPECIES; SPINAL CORD;

EID: 84924530072     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402302     Document Type: Article

References (49)

1. Ruggieri, S., C. Tortorella, and C. Gasperini. 2014. Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis. Ther Clin Risk Manag 10: 229-239.
2. Linker, R. A., D. H. Lee, S. Ryan, A. M. van Dam, R. Conrad, P. Bista, W. Zeng, X. Hronowsky, A. Buko, S. Chollate, et al. 2011. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134: 678-692.
3. Schmidt, T. J., M. Ak, and U. Mrowietz. 2007. Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-L-cysteine-preparation of S-substituted thiosuccinic acid esters. Bioorg. Med. Chem. 15: 333-342.
4. Lin, S. X., L. Lisi, C. Dello Russo, P. E. Polak, A. Sharp, G. Weinberg, S. Kalinin, and D. L. Feinstein. 2011. The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro 3: e00055.
5. Miljković, D., and I. Spasojević. 2013. Multiple sclerosis: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 19: 2286-2334.
6. Gelderman, K. A., M. Hultqvist, J. Holmberg, P. Olofsson, and R. Holmdahl. 2006. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc. Natl. Acad. Sci. USA 103: 12831-12836.
7. Yan, Z., and R. Banerjee. 2010. Redox remodeling as an immunoregulatory strategy. Biochemistry 49: 1059-1066.
8. Yan, Z., S. K. Garg, and R. Banerjee. 2010. Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells. J. Biol. Chem. 285: 41525-41532.
9. Halliwell, B. 2013. The antioxidant paradox: less paradoxical now? Br. J. Clin. Pharmacol. 75: 637-644.
10. Han, Y., J. A. Englert, R. Yang, R. L. Delude, and M. P. Fink. 2005. Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65. J. Pharmacol. Exp. Ther. 312: 1097-1105.
11. Kao, K. K., and M. P. Fink. 2010. The biochemical basis for the antiinflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem. Pharmacol. 80: 151-159.
12. Shin, J. H., S. W. Kim, Y. Jin, I. D. Kim, and J. K. Lee. 2012. Ethyl pyruvatemediated Nrf2 activation and hemeoxygenase 1 induction in astrocytes confer protective effects via autocrine and paracrine mechanisms. Neurochem. Int. 61: 89-99.
13. Kim, S. W., H. K. Lee, J. H. Shin, and J. K. Lee. 2013. Up-down regulation of HO-1 and iNOS gene expressions by ethyl pyruvate via recruiting p300 to Nrf2 and depriving It from p65. Free Radic. Biol. Med. 65: 468-476.
14. Fink, M. P. 2007. Ethyl pyruvate: a novel anti-inflammatory agent. J. Intern. Med. 261: 349-362.
15. Kalariya, N. M., A. B. Reddy, N. H. Ansari, F. J. VanKuijk, and K. V. Ramana. 2011. Preventive effects of ethyl pyruvate on endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 52: 5144-5152.
16. Tang, H., H. Zhao, J. Song, H. Dong, L. Yao, Z. Liang, Y. Lv, F. Zou, and S. Cai. 2014. Ethyl pyruvate decreases airway neutrophil infiltration partly through a high mobility group box 1-dependent mechanism in a chemical-induced murine asthma model. Int. Immunopharmacol. 21: 163-170.
17. Kim, J. B., Y. M. Yu, S. W. Kim, and J. K. Lee. 2005. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res. 1060: 188-192.
18. Su, X., H. Wang, L. Zhu, J. Zhao, H. Pan, and X. Ji. 2013. Ethyl pyruvate ameliorates intracerebral hemorrhage-induced brain injury through anti-cell death and anti-inflammatory mechanisms. Neuroscience 245: 99-108.
19. Shi, H., H. L. Wang, H. J. Pu, Y. J. Shi, J. Zhang, W. T. Zhang, G. H. Wang, X. M. Hu, R. K. Leak, J. Chen, and Y. Q. Gao. 2014. Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury. CNS Neurosci. Ther. 1. 1111/cns.12366.
20. Choi, J. S., M. S. Lee, and J. W. Jeong. 2010. Ethyl pyruvate has a neuroprotective effect through activation of extracellular signal-regulated kinase in Parkinson's disease model. Biochem. Biophys. Res. Commun. 394: 854-858.
21. di Penta, A., B. Moreno, S. Reix, B. Fernandez-Diez, M. Villanueva, O. Errea, N. Escala, K. Vandenbroeck, J. X. Comella, and P. Villoslada. 2013. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS ONE 8: e54722.
22. Jang, M., M. J. Lee, and I. H. Cho. 2014. Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and antiinflammatory mechanisms. Brain Behav. Immun. 38: 151-165.
23. Wekerle, H. 2008. Lessons from multiple sclerosis: models, concepts, observations. Ann. Rheum. Dis. 67(Suppl. 3): iii56-iii60.
24. Petermann, F., and T. Korn. 2011. Cytokines and effector T cell subsets causing autoimmune CNS disease. FEBS Lett. 585: 3747-3757.
25. Chastain, E. M., D. S. Duncan, J. M. Rodgers, and S. D. Miller. 2011. The role of antigen presenting cells in multiple sclerosis. Biochim. Biophys. Acta 1812: 265-274.
26. Zindler, E., and F. Zipp. 2010. Neuronal injury in chronic CNS inflammation. Best Pract. Res. Clin. Anaesthesiol. 24: 551-562.
27. Miljković, D., G. Timotijević, and M. Mostarica Stojković. 2011. Astrocytes in the tempest of multiple sclerosis. FEBS Lett. 585: 3781-3788.
28. Goldmann, T., and M. Prinz. 2013. Role of microglia in CNS autoimmunity. Clin. Dev. Immunol. 2013: 208093.
29. Miljković, D., Z. Stanojević, M. Momcilović, F. Odoardi, A. Flügel, and M. Mostarica-Stojković. 2011. CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats. Immunobiology 216: 979-987.
30. Boltz-Nitulescu, G., C. Wiltschke, C. Holzinger, A. Fellinger, O. Scheiner, A. Gessl, and O. Förster. 1987. Differentiation of rat bone marrow cells into macrophages under the influence of mouse L929 cell supernatant. J. Leukoc. Biol. 41: 83-91.
31. McCarthy, K. D., and J. de Vellis. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85: 890-902.
32. Spasojević, I. 2011. Free radicals and antioxidants at a glance using EPR spectroscopy. Crit. Rev. Clin. Lab. Sci. 48: 114-142.
33. Pristov, J. B., A. Mitrović, and I. Spasojević. 2011. A comparative study of antioxidative activities of cell-wall polysaccharides. Carbohydr. Res. 346: 2255-2259.
34. Schneider, A., S. A. Long, K. Cerosaletti, C. T. Ni, P. Samuels, M. Kita, and J. H. Buckner. 2013. In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling. Sci. Transl. Med. 5: 170ra15.
35. Brambilla, R., J. J. Ashbaugh, R. Magliozzi, A. Dellarole, S. Karmally, D. E. Szymkowski, and J. R. Bethea. 2011. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 134: 2736-2754.
36. Lucchinetti, C. F., B. F. Popescu, R. F. Bunyan, N. M. Moll, S. F. Roemer, H. Lassmann, W. Brück, J. E. Parisi, B. W. Scheithauer, C. Giannini, et al. 2011. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365: 2188-2197.
37. Bullard, D. C., X. Hu, T. R. Schoeb, R. C. Axtell, C. Raman, and S. R. Barnum. 2005. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J. Immunol. 175: 6327-6333.
38. Andrades, M. É ., A. Morina, S. Spasić, and I. Spasojević. 2011. Bench-tobedside review: sepsis-from the redox point of view. Crit. Care 15: 230.
39. Khasnavis, S., A. Jana, A. Roy, M. Mazumder, B. Bhushan, T. Wood, S. Ghosh, R. Watson, and K. Pahan. 2012. Suppression of nuclear factor-kB activation and inflammation in microglia by physically modified saline. J. Biol. Chem. 287: 29529-29542.
40. Wilms, H., J. Sievers, U. Rickert, M. Rostami-Yazdi, U. Mrowietz, and R. Lucius. 2010. Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation. J. Neuroinflammation 7: 30.
41. Bonetti, B., C. Stegagno, B. Cannella, N. Rizzuto, G. Moretto, and C. S. Raine. 1999. Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. Am. J. Pathol. 155: 1433-1438.
42. Raasch, J., N. Zeller, G. van Loo, D. Merkler, A. Mildner, D. Erny, K. P. Knobeloch, J. R. Bethea, A. Waisman, M. Knust, et al. 2011. IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system. Brain 134: 1184-1198.
43. Smith, K. J. 2011. Newly lesioned tissue in multiple sclerosis-a role for oxidative damage? Brain 134: 1877-1881.
44. Wang, Y., B. Li, Z. Li, S. Huang, J. Wang, and R. Sun. 2013. Improvement of hypoxia-ischemia-induced white matter injury in immature rat brain by ethyl pyruvate. Neurochem. Res. 38: 742-752.
45. Wang, Y., P. Yin, S. Huang, J. Wang, and R. Sun. 2013. Ethyl pyruvate protects against lipopolysaccharide-induced white matter injury in the developing rat brain. Int. J. Dev. Neurosci. 31: 181-188.
46. Yuan, Y., Z. Su, Y. Pu, X. Liu, J. Chen, F. Zhu, Y. Zhu, H. Zhang, and C. He. 2012. Ethyl pyruvate promotes spinal cord repair by ameliorating the glial microenvironment. Br. J. Pharmacol. 166: 749-763.
47. Zeng, J., J. Liu, G. Y. Yang, M. J. Kelly, T. L. James, and L. Litt. 2007. Exogenous ethyl pyruvate versus pyruvate during metabolic recovery after oxidative stress in neonatal rat cerebrocortical slices. Anesthesiology 107: 630-640.
48. Bennett-Guerrero, E., M. Swaminathan, A. M. Grigore, G. W. Roach, L. G. Aberle, J. M. Johnston, and M. P. Fink. 2009. A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 23: 324-329.
49. Schuh, C., I. Wimmer, S. Hametner, L. Haider, A. M. Van Dam, R. S. Liblau, K. J. Smith, L. Probert, C. J. Binder, J. Bauer, et al. 2014. Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol. 128: 247-266.